-
Ismagilov Lab, California Institute of Technology | Pasadena, California | United States | about 1 month ago
includes development of scientific knowledge and technologies to impact human health, in particular in areas of emerging human pathogens, human host-microbe interactions, and human immune response
-
of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal
-
to contribute to selection of targets for progression from chemical/biologic synthesis to testing in human. Leads the creation of the clinical development plan from pre-clinical stages through to proof of concept
-
eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and
-
does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other
-
of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal
-
to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility. Sunshine Act Pfizer reports payments and other transfers of value
-
and will work closely with DGSOM leadership including the DGSOM Dean, Vice Dean for Research, and CTSI leadership. Research activities are based in the 25,000 square foot J. Vernon Luck, Sr., M.D
-
; the Institute for Human Genetics and the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco; and Lawrence Berkeley National Lab. The Brenner Research Group is